Narrative review / 2012
Historical use of DES in medicine and livestock feed highlights its legacy as an endocrine disruptor linked to cancer and potential obesogenic effects.
This review examines the long-term impacts of diethylstilboestrol (DES), an endocrine disrupter that causes cancer in rodents and was previously prescribed for women with gynaecological problems. Some daughters of these women subsequently developed vaginal clear cell adenocarcinoma, and genital abnormalities were found in some sons. DES was used for decades in livestock feed, which may have contaminated the food chain and exposed the general population. It appears to cause epigenetic effects in animals with some evidence in humans, and it has been suggested that DES may have acted as an obesogen, though proving mechanisms is difficult due to dietary and environmental phyto- and xenooestrogens.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Human populations, including offspring of women prescribed DES
- What was measured
- Carcinogenesis, genital abnormalities, obesogen effects, and food contamination
THE PAPER
Diethylstilboestrol--a long-term legacy.
Harris RM, Waring RH. Maturitas, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.